As a condition of the emergency use authorizations issued for the Pfizer/BioNTech and Moderna coronavirus vaccines, those companies are expected to work toward asking the US Food and Drug Administration for full approval — and some health officials are hoping it will happen soon.

What to Expect from a Potential Trump Administration in 2025
As Donald Trump campaigns for a potential return to the presidency, speculation grows about what his administration might prioritize and how it would shape the